Business & Regulation

Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study.

A new not-for-profit company will manufacture important generics in the US

Which biopharma positions are hardest to fill? What skills are most in demand? And what can companies do to ensure they discover and nurture talent?

Why are we still making life difficult for a growing patient population when solutions exist?

First-of-its-kind Parkinson’s trial, Brexit woes, and a vaccine scandal in China… What’s new for pharma in business?

Do methods that compare newly approved drugs with those already on the market help cut healthcare costs?

Most, but not all, UK pharma companies are on track to keep their medicines on the European market by March, 2019.

Thought that most companies understood good manufacturing practice? Think again – there are always a few bad eggs.

Sitting Down With... Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.

We examine the most commercially important biotherapeutics now, and in the future.